Furthermore, immune checkpoint receptors such as PD-1 and TIM-3 play a role in regulating T-cell responses during chronic HIV infection, suggesting that combining immune checkpoint blockade with vaccine strategies may improve T-cell functionality and overall immune responses (185, 186). This evidence concerns the gene HAVCR2 and HIV infectious disease.